MK0767 Glipizide Comparator Cardiac Safety Study (0767-018)

Summary

A study to evaluate the cardiac and metabolic effects of MK0767 in patients with Type 2 Diabetes. This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).

Timeline

Start

2002-11

Primary completion

2003-11

Completion

2003-11

Drugs

Indications